Meeting of the Advisory Committee on Blood Safety and Availability, 52492 [E9-24483]
Download as PDF
<![CDATA[
52492
Federal Register / Vol. 74, No. 196 / Tuesday, October 13, 2009 / Notices
that strive to augment the informed
consent document and increase a
subject’s understanding of research
participation. The meeting will
conclude with a panel of speakers
focusing on the regulatory barriers that
may be associated with Community
Based and Participatory Research.
Public comment will be heard on both
days.
Public attendance at the meeting is
limited to space available. Individuals
who plan to attend the meeting and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the designated contact persons.
Members of the public will have the
opportunity to provide comments on
both days of the meeting. Public
comment will be limited to five minutes
per speaker. Any members of the public
who wish to have printed materials
distributed to SACHRP members for this
scheduled meeting should submit
materials to the Executive Director,
SACHRP, prior to the close of business
Thursday, October 22, 2009.
Information about SACHRP and the
draft meeting agenda will be posted on
the SACHRP Web site at: https://
www.hhs.gov/ohrp/sachrp/.
Dated: October 6, 2009.
Jerry Menikoff,
Director, Office for Human Research
Protections, Executive Secretary, Secretary’s
Advisory Committee on Human Research
Protections.
[FR Doc. E9–24482 Filed 10–9–09; 8:45 am]
BILLING CODE 4150–36–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Advisory Committee on
Blood Safety and Availability
erowe on DSK5CLS3C1PROD with NOTICES
AGENCY: Department of Health and
Human Services, Office of the Secretary.
ACTION: Notice.
SUMMARY: As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Services is hereby giving notice that the
Advisory Committee on Blood Safety
and Availability (ACBSA) will hold a
meeting. The meeting will be open to
the public.
DATES: The meeting will take place
Thursday, November 19 and Friday,
November 20, 2009 from 8:30 a.m. to 5
p.m.
ADDRESSES: The Universities at Shady
Grove, 9630 Gudelsky Drive, Rockville,
MD 20850, Phone: 301–738–6000.
FOR FURTHER INFORMATION CONTACT: Jerry
A. Holmberg, PhD, Executive Secretary,
VerDate Nov<24>2008
15:29 Oct 09, 2009
Jkt 220001
Advisory Committee on Blood Safety
and Availability, Office of Public Health
and Science, Department of Health and
Human Services, 1101 Wootton
Parkway, Suite 250, Rockville, MD
20852, (240) 453–8803, FAX (240) 453–
8456, e-mail ACBSA@hhs.gov.
SUPPLEMENTARY INFORMATION: The
Advisory Committee on Blood Safety
and Availability provides advice to the
Secretary and the Assistant Secretary for
Health on a range of policy issues that
impact (1) Definition of public health
parameters around safety and
availability of the blood supply and
blood products, (2) broad public health,
ethical and legal issues related to
transfusion and transplantation safety,
and (3) the implications for safety and
the availability of various economic
factors affecting product cost and
supply.
In keeping with its established
mission, the ACBSA has been asked to
review and comment on the current
processes and parameters which should
be used in the decision-making process
for transplantation safety policy. At the
November 19 and 20, 2009 meeting, the
Committee will be asked to comment
and make recommendations on current
safety decision making processes within
the Department of Health and Human
Services while considering those same
processes within the Private Sector.
During the meeting, the ACBSA will
be provided a briefing on Biovigilance
(surveillance of blood, organs, and
tissues safety). Specifically, the
committee will be asked to comment on
the white paper entitled, ‘‘Biovigilance
in the United States: Efforts to Bridge a
Critical Gap in Patient Safety and Donor
Health.’’
The public will have opportunity to
present their views to the Committee on
both meeting days. A public comment
session has been scheduled for
November 19 and 20, 2009. Comments
will be limited to five minutes per
speaker and must be pertinent to the
discussion. Pre-registration is required
for participation in the public comment
session. Any member of the public who
would like to participate in this session
is encouraged to contact the Executive
Secretary at his/her earliest
convenience. It is requested that those
who wish to have printed material
distributed to the Committee provide
thirty (30) copies of the document to be
distributed to the Executive Secretary,
ACBSA, prior to close of business
November 16, 2009. If it is not possible
to provide 30 copies of the material to
be distributed, then individuals are
requested to provide at a minimum one
(1) copy of the document(s) to be
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
distributed prior to the close of business
November 16, 2009. It also is requested
that any member of the public who
wishes to provide comments to the
Committee utilizing electronic data
projection submit the necessary material
to the Executive Secretary prior to close
of business November 16, 2009.
Dated: September 25, 2009.
Jerry A. Holmberg,
Executive Secretary, Advisory Committee on
Blood Safety and Availability.
[FR Doc. E9–24483 Filed 10–9–09; 8:45 am]
BILLING CODE 4150–41–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–10–0612]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Maryam Daneshvar,
CDC Acting Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Well-Integrated Screening and
Evaluation for Women Across the
Nation (WISEWOMAN) Reporting
System (OMB #0920–0612, exp.
1/31/2010)—Revision—National Center
E:\FR\FM\13OCN1.SGM
13OCN1
]]>Agencies
[Federal Register Volume 74, Number 196 (Tuesday, October 13, 2009)]
[Notices]
[Page 52492]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-24483]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Advisory Committee on Blood Safety and
Availability
AGENCY: Department of Health and Human Services, Office of the
Secretary.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S.
Department of Health and Human Services is hereby giving notice that
the Advisory Committee on Blood Safety and Availability (ACBSA) will
hold a meeting. The meeting will be open to the public.
DATES: The meeting will take place Thursday, November 19 and Friday,
November 20, 2009 from 8:30 a.m. to 5 p.m.
ADDRESSES: The Universities at Shady Grove, 9630 Gudelsky Drive,
Rockville, MD 20850, Phone: 301-738-6000.
FOR FURTHER INFORMATION CONTACT: Jerry A. Holmberg, PhD, Executive
Secretary, Advisory Committee on Blood Safety and Availability, Office
of Public Health and Science, Department of Health and Human Services,
1101 Wootton Parkway, Suite 250, Rockville, MD 20852, (240) 453-8803,
FAX (240) 453-8456, e-mail ACBSA@hhs.gov.
SUPPLEMENTARY INFORMATION: The Advisory Committee on Blood Safety and
Availability provides advice to the Secretary and the Assistant
Secretary for Health on a range of policy issues that impact (1)
Definition of public health parameters around safety and availability
of the blood supply and blood products, (2) broad public health,
ethical and legal issues related to transfusion and transplantation
safety, and (3) the implications for safety and the availability of
various economic factors affecting product cost and supply.
In keeping with its established mission, the ACBSA has been asked
to review and comment on the current processes and parameters which
should be used in the decision-making process for transplantation
safety policy. At the November 19 and 20, 2009 meeting, the Committee
will be asked to comment and make recommendations on current safety
decision making processes within the Department of Health and Human
Services while considering those same processes within the Private
Sector.
During the meeting, the ACBSA will be provided a briefing on
Biovigilance (surveillance of blood, organs, and tissues safety).
Specifically, the committee will be asked to comment on the white paper
entitled, ``Biovigilance in the United States: Efforts to Bridge a
Critical Gap in Patient Safety and Donor Health.''
The public will have opportunity to present their views to the
Committee on both meeting days. A public comment session has been
scheduled for November 19 and 20, 2009. Comments will be limited to
five minutes per speaker and must be pertinent to the discussion. Pre-
registration is required for participation in the public comment
session. Any member of the public who would like to participate in this
session is encouraged to contact the Executive Secretary at his/her
earliest convenience. It is requested that those who wish to have
printed material distributed to the Committee provide thirty (30)
copies of the document to be distributed to the Executive Secretary,
ACBSA, prior to close of business November 16, 2009. If it is not
possible to provide 30 copies of the material to be distributed, then
individuals are requested to provide at a minimum one (1) copy of the
document(s) to be distributed prior to the close of business November
16, 2009. It also is requested that any member of the public who wishes
to provide comments to the Committee utilizing electronic data
projection submit the necessary material to the Executive Secretary
prior to close of business November 16, 2009.
Dated: September 25, 2009.
Jerry A. Holmberg,
Executive Secretary, Advisory Committee on Blood Safety and
Availability.
[FR Doc. E9-24483 Filed 10-9-09; 8:45 am]
BILLING CODE 4150-41-P
